Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXL20020941	硝呋太尔制霉素阴道软胶囊	nifuratel;nystatin	Soft capsules	Chemical Drugs(4)	New Drug Application	2002-06-03	北京瑞康明药物研究所	Beijing Ruikangming Pharmaceutical Research Institute	Certificate Issued	2003-11-07	view
CXL00487	匹多莫德散剂	pidotimod	Powder	Chemical Drugs(4)	New Drug Application	2001-01-18	北京瑞康明药物研究所	Beijing Ruikangming Pharmaceutical Research Institute	Certificate Issued	2001-12-03	view
X0402050	注射用匹多莫德	pidotimod	Lyophilized	Chemical Drugs(2)	New Drug Application	2005-01-13	北京瑞康明药物研究所	Beijing Ruikangming Pharmaceutical Research Institute	Certificate Issued	2005-04-22	view
CXL20020940	硝呋太尔	nifuratel	Active ingredient	Chemical Drugs(4)	New Drug Application	2002-06-03	北京瑞康明药物研究所	Beijing Ruikangming Pharmaceutical Research Institute	Certificate Issued	2003-11-07	view
CXL20021174G	氢溴酸西酞普兰	citalopram hydrobromide	Active ingredient	Chemical Drugs(4)	New Drug Application	2002-07-22	北京瑞康明药物研究所	Beijing Ruikangming Pharmaceutical Research Institute	Certificate Issued	2003-12-29	view
CXL01A32G	劳诺昔康片		Tablet	Chemical Drugs(2)	New Drug Application	2001-11-23	北京瑞康明药物研究所	Beijing Ruikangming Pharmaceutical Research Institute	Approval Completed-Pending Certificated	2003-04-03	view
CXL20021175G	氢溴酸西酞普兰片	citalopram hydrobromide	Tablet	Chemical Drugs(4)	New Drug Application	2002-07-22	北京瑞康明药物研究所	Beijing Ruikangming Pharmaceutical Research Institute	Certificate Issued	2003-12-29	view
CXL01A31G	劳诺昔康		Active ingredient	Chemical Drugs(2)	New Drug Application	2001-11-23	北京瑞康明药物研究所	Beijing Ruikangming Pharmaceutical Research Institute	Approval Completed-Pending Certificated	2003-04-03	view